New US rules on paediatric labelling may raise costs Newsletter Article 09 February 2013 Pages: 2 - 2
Disease management no longer a ‘buzzword’ in the US Carlene Todd Newsletter Article 09 February 2013 Pages: 3 - 4
Switching ceftizoxime for cefotaxime proves cost saving Newsletter Article 09 February 2013 Pages: 5 - 5
Determinants of polypharmacy in elderly nursing-home residents Newsletter Article 09 February 2013 Pages: 5 - 5
Abciximab a promising option for high-risk PTCA patients Newsletter Article 09 February 2013 Pages: 6 - 6
‘As-needed’ use of β-agonists appropriate and cost saving Newsletter Article 09 February 2013 Pages: 7 - 7
Specialist vs generalist prescribing in atopic dermatitis Newsletter Article 09 February 2013 Pages: 7 - 7
Cefpodoxime proxetil cost saving for recurrent pharyngotonsillitis Newsletter Article 09 February 2013 Pages: 7 - 7
Depot antipsychotics may reduce costs for some patients Newsletter Article 09 February 2013 Pages: 8 - 8
Combined radio- and antineoplastic therapy justified for colorectal cancer Newsletter Article 09 February 2013 Pages: 8 - 9
New measures to control healthcare expenditure in Germany Newsletter Article 09 February 2013 Pages: 11 - 11
French prescribing and dispensing data to be computerised Newsletter Article 09 February 2013 Pages: 12 - 12